Partnership
We cultivate lasting strategic partnerships with research institutions, cancer treatment centers, biopharmaceutical companies, and nonprofits to facilitate innovation in IO and advance new lifesaving immunotherapies for more patients.
Corporate Partnerships
CRI leverages its role as a science-first nonprofit to forge discovery-driven partnerships with leading biotech and pharmaceutical companies committed to advancing immuno-onology. CRI also partners with corporations committed to providing accessible, trusted information to the communities they serve.
Educational Partnerships
Through educational partnerships with prominent cancer research and treatment centers as well as patient community support organizations, CRI is able to connect more people to the science of cancer immunotherapy while featuring expert perspectives on the field and empowering patients to explore their immunotherapy options and clinical trials.
Research Partnerships
CRI proudly partners with other nonprofit organizations to co-fund research projects that draw upon CRI’s expertise in immunotherapy and apply it to the study of rare or hard-to-treat cancers. CRI also supports academic journal publishing as well as provides dedicated funding for immunology research in specific countries around the world.
CRI Leadership Council Corporate Sponsors
The following companies are members of the CRI Leadership Council and provide support and strategic guidance to advance CRI’s mission. Their participation reflects a shared commitment to accelerating innovation in cancer immunotherapy and strengthening collaboration across the oncology community.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.